IL17A and cancer: This Th17-dominant cytokine environment, characterised by high levels of IL-17, RORγt, and IL-23R expression in mucosal CD4+ T cells, creates a feedback loop that perpetuates chronic inflammation and facilitates the transformation of cancer cells [87].